BioMarin Pharmaceutical, Inc. (BMRN)
59.45
+0.46
(+0.78%)
USD |
NASDAQ |
Dec 31, 16:00
59.45
0.00 (0.00%)
After-Hours: 16:07
BioMarin Pharmaceutical Free Cash Flow: 825.79M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amicus Therapeutics, Inc. | 9.691M |
| Gilead Sciences, Inc. | 9.162B |
| Merck & Co., Inc. | 13.05B |
| AbbVie, Inc. | 19.68B |
| Bristol Myers Squibb Co. | 15.30B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 368.68M |
| Cash from Investing (Quarterly) | -330.96M |
| Cash from Financing (Quarterly) | -2.169M |
| Free Cash Flow Per Share (Quarterly) | 1.744 |
| Free Cash Flow to Equity (Quarterly) | 335.63M |
| Free Cash Flow to Firm (Quarterly) | 337.95M |
| Free Cash Flow Yield | 7.10% |